Everything You Need To Know About A Potential Breast Cancer Vaccine
Cleveland Clinic researchers recently opened a study for a vaccine aimed at eventually preventing triple-negative breast cancer, which is the most aggressive form of breast cancer. In this phase I trial, researchers are hoping to determine the maximum tolerated dose in patients with early-stage triple-negative breast cancer in hope of optimizing the body’s immune response. Because people with triple-negative breast cancer don’t typically respond to hormone or other targeted treatments, a vaccine would completely change the nature of the disease for these patients....